Bayer to buy VC-backed vitamin company Care/of: Bloomberg

Bayer has agreed to acquire vitamin company Care/of, reported Bloomberg. The news outlet noted that the transaction will put Care/of at a $225 million valuation.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this